Cargando…

Conventional Vasopressor and Vasopressor‐Sparing Strategies to Counteract the Blood Pressure–Lowering Effect of Small Interfering RNA Targeting Angiotensinogen

BACKGROUND: A single dose of small interfering RNA (siRNA) targeting liver angiotensinogen eliminates hepatic angiotensinogen and lowers blood pressure. Angiotensinogen elimination raises concerns for clinical application because an angiotensin rise is needed to maintain perfusion pressure during hy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Uijl, Estrellita, Ye, Dien, Ren, Liwei, Mirabito Colafella, Katrina M., van Veghel, Richard, Garrelds, Ingrid M., Lu, Hong S., Daugherty, Alan, Hoorn, Ewout J., Nioi, Paul, Foster, Don, Danser, A. H. Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375483/ https://www.ncbi.nlm.nih.gov/pubmed/35876413 http://dx.doi.org/10.1161/JAHA.122.026426

Ejemplares similares

Small Interfering RNA Therapeutics in Hypertension: A Viewpoint on Vasopressor and Vasopressor‐Sparing Strategies for Counteracting Blood Pressure Lowering by Angiotensinogen–Targeting Small Interfering RNA
por: Ranasinghe, Priyanga, et al.
Publicado: (2022)

Angiotensinogen Suppression: A New Tool to Treat Cardiovascular and Renal Disease
por: Cruz-López, Edwyn O., et al.
Publicado: (2022)

Blood pressure‐independent renoprotective effects of small interference RNA targeting liver angiotensinogen in experimental diabetes
por: Cruz‐López, Edwyn O., et al.
Publicado: (2022)

Vasopressor stays vasopressor and inotrope stays inotrope!
por: Luckner, Günter, et al.
Publicado: (2008)

Targeting Angiotensinogen With N-Acetylgalactosamine–Conjugated Small Interfering RNA to Reduce Blood Pressure
por: Ye, Dien, et al.
Publicado: (2023)

Timeliness of administration of vasopressors in CPR
por: Grmec, Stefek, et al.
Publicado: (2009)

Vasopressor-Induced Digital Ischemia
por: Jesani, Shruti, et al.
Publicado: (2021)

Are Vasopressors an Enemy of the Coronary Arteries?
por: Rubini Gimenez, Maria, et al.
Publicado: (2019)

From ARB to ARNI in Cardiovascular Control
por: Uijl, Estrellita, et al.
Publicado: (2016)

VASOPRESSOR-RESISTANT HYPOTENSION, COMBINATION VASOPRESSOR THERAPY, AND SHOCK PHENOTYPES IN CRITICALLY ILL ADULTS WITH VASODILATORY SHOCK
por: Priyanka, Priyanka, et al.
Publicado: (2022)

Vasopressor-Sparing Action of Methylene Blue in Severe Sepsis and Shock: A Narrative Review
por: Puntillo, Filomena, et al.
Publicado: (2020)

Current use of vasopressors in septic shock
por: Scheeren, Thomas W. L., et al.
Publicado: (2019)

Effects of Length of Vasopressors Infusion on Mortality
por: Kumar, Vikas, et al.
Publicado: (2019)

Vasopressors in Septic Shock: The Quest for Refinement
por: Pichamuthu, Kishore
Publicado: (2022)

Improving vasopressor use in cardiac arrest
por: Perkins, Gavin D., et al.
Publicado: (2023)

"Vasopressor Support Sparing Strategies": a Concept to be Incorporated as a Paradigm in the Treatment of Vasodilatory Shock
por: Evora, Paulo Roberto B., et al.
Publicado: (2019)

Vasopressor-Sparing Strategies in Patients with Shock: A Scoping-Review and an Evidence-Based Strategy Proposition
por: Guinot, Pierre-Grégoire, et al.
Publicado: (2021)

Optimal vasopressor drug therapy during resuscitation
por: Ornato, Joseph P
Publicado: (2008)

Choice of vasopressor in septic shock: does it matter?
por: Patel, Gourang P, et al.
Publicado: (2007)

Customized modeling to predict the use of vasopressors in ICUs
por: Fialho, A, et al.
Publicado: (2012)

Hypotension in ICU Patients Receiving Vasopressor Therapy
por: Yapps, Bryce, et al.
Publicado: (2017)

Vasopressor Therapy and the Brain: Dark Side of the Moon
por: Heming, Nicholas, et al.
Publicado: (2020)

Dobutamine/vasopressors: Lack of efficacy: case report
Publicado: (2021)

Administration of vasopressors through peripheral venous catheters
por: Araiza, Alan, et al.
Publicado: (2022)

Perceptions and Barriers to Administering Vasopressors in the Prehospital Setting
por: Quinn, Eric, et al.
Publicado: (2022)

Combining fluids and vasopressors: A magic potion?
por: Hamzaoui, Olfa
Publicado: (2021)

Fluids or vasopressors for the initial resuscitation of septic shock
por: Macdonald, Stephen, et al.
Publicado: (2022)

Vasopressor weaning in sepsis: Debate is being continued!
por: Bhattacharjee, Sulagna, et al.
Publicado: (2023)

Influence of vasopressor agent in pediatric septic shock mortality
por: Mangia, CMF, et al.
Publicado: (2011)

Challenging the rationale of routine vasopressor therapy for management of hypotension
por: Weil, Max Harry, et al.
Publicado: (2009)

Norepinephrine: more of a neurohormone than a vasopressor
por: Myburgh, John
Publicado: (2010)

Does vasopressor therapy have an indication in hemorrhagic shock?
por: Beloncle, François, et al.
Publicado: (2013)

Is there still a place for vasopressors in the treatment of cardiac arrest?
por: Sandroni, Claudio, et al.
Publicado: (2012)

Therapeutic Strategies for High-Dose Vasopressor-Dependent Shock
por: Bassi, Estevão, et al.
Publicado: (2013)

Vasopressors and inotropes in cardiogenic shock: is there room for “adrenaline resuscitation”?
por: Morici, Nuccia, et al.
Publicado: (2016)

Risk Factors of Vasopressor-Induced Symmetrical Peripheral Gangrene
por: Kwon, Jung Woo, et al.
Publicado: (2018)

Vitamin D and Postoperative Vasopressor Use in Cardiopulmonary Bypass
por: Javorski, Michael J., et al.
Publicado: (2018)

Vasopressors: Do they have any role in hemorrhagic shock?
por: Gupta, Babita, et al.
Publicado: (2017)

Vasopressors in septic shock: which, when, and how much?
por: Shi, Rui, et al.
Publicado: (2020)

Modeling of Usual Care: Vasopressor Initiation for Sepsis With Hypotension
por: Prasad, Varesh, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oqn7obkdbb1ve9u5j4u3cbh36v